Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,087 | 22,792 | 132,325 | 15,365 | 131,650 |
| Marketable Securities | 353,208 | 252,449 | 41,393 | 60,125 | 45,276 |
| Receivables | 52 | 807 | 478 | 5,638 | N/A |
| TOTAL | $409,438 | $280,904 | $177,451 | $82,033 | $180,693 |
| Non-Current Assets | |||||
| PPE Net | 296 | 194 | 185 | 142 | 7,461 |
| Investments And Advances | 110,135 | 81,728 | 0 | 0 | 0 |
| Other Non-Current Assets | 11,053 | 11,182 | 1,769 | 935 | 1,780 |
| TOTAL | $121,484 | $93,104 | $1,954 | $1,077 | $9,241 |
| Total Assets | $530,922 | $374,008 | $179,405 | $83,110 | $189,934 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,725 | 4,579 | 2,610 | 1,167 | 3,040 |
| Accrued Expenses | 19,452 | 13,074 | 6,504 | 6,608 | 7,823 |
| TOTAL | $30,732 | $18,452 | $9,631 | $8,225 | $10,863 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,188 | 479 | 100 | 100 | N/A |
| Other Non-Current Liabilities | 1,019 | 1,171 | 168 | 438 | 0 |
| TOTAL | $6,789 | $3,079 | $904 | $1,229 | $6,399 |
| Total Liabilities | $37,521 | $21,531 | $10,535 | $9,454 | $17,262 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,471 | 32,125 | 29,347 | 3,790 | 3,675 |
| Common Shares | 43 | 31 | 15 | N/A | 59 |
| Retained earnings | -336,729 | -174,392 | -89,423 | -45,868 | -325,567 |
| Other shareholders' equity | 489 | 106 | 47 | 117,863 | -30 |
| TOTAL | $493,401 | $352,477 | $168,870 | $73,656 | $172,672 |
| Total Liabilities And Equity | $530,922 | $374,008 | $179,405 | $83,110 | $189,934 |